The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
January 25, 2011 updated by: Gachon University Gil Medical Center
Study of the Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
Identification of the pathophysiology associated with Eisenmenger's syndrome has led to the evaluation of targeted therapies.
Iloprost, a prostacyclin analogue, is one such targeted therapy used in patients with Eisenmenger's syndrome.
The purpose of our study is to assess the effects of inhaled iloprost on patients with Eisenmenger's syndrome.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
12
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
12 patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization
Description
Inclusion Criteria:
- patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization
Exclusion Criteria:
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2007
Study Completion (ACTUAL)
May 1, 2010
Study Registration Dates
First Submitted
January 25, 2011
First Submitted That Met QC Criteria
January 25, 2011
First Posted (ESTIMATE)
January 26, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
January 26, 2011
Last Update Submitted That Met QC Criteria
January 25, 2011
Last Verified
May 1, 2010
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- No sponsor
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Eisenmenger's Syndrome
-
University of California, Los AngelesActelionTerminatedPulmonary Arterial Hypertension | Congenital Heart Disease | Eisenmenger's SyndromeUnited States
-
GlaxoSmithKlineNot yet recruiting
-
Rutgers, The State University of New JerseyRecruitingMicrodeletion 3q29 Syndrome | Microduplication 3q29 SyndromeUnited States
-
Lokman Hekim UniversityCompletedSubacromial Impingement Syndrome | Shoulder Impingement Syndrome | Rotator Cuff Impingement SyndromeTurkey (Türkiye)
-
Cairo UniversityCompleted
-
Cairo UniversityCompleted
-
Ministry of Public Health, Democratic Republic...National Institutes of Health (NIH); Oregon Health and Science University; National... and other collaboratorsCompletedNeurotoxicity Syndrome, Cassava | Neurotoxicity Syndrome, Cyanate | Neurotoxicity Syndrome, Cyanide | Neurotoxicity Syndrome, ThiocyanateCongo, The Democratic Republic of the
-
Unravel Biosciences, Inc.RecruitingPitt Hopkins SyndromeColombia
-
Neumedicines Inc.Department of Health and Human ServicesCompletedHematopoietic Syndrome Due to Acute Radiation SyndromeUnited States
-
Mahidol UniversityCompletedSubacromial Impingement Syndrome | Shoulder Impingement Syndrome | Subacromial Pain Syndrome | Subacromial Impingement | Impingement Syndrome, ShoulderIndonesia